IGF1 and breast cancer: Overexpression of insulin-like growth factors 1 and 2 (key regulators of breast cancer development) in breast cancer tissues leads to increased expression of asparagine synthetase, which, in turn, alters the levels of asparagine and aspartate (Xie et al., 2015).